Reprogramming-that it succeeds at allis startling. To prevent cancer, evolution has invested wisely in epigenetic mechanisms that maintain stable cell identity; thus, it's mind-boggling that a few factors, ectopically expressed, can compel a somatic cell to revert to infancy or to change careers via transdifferentiation. 
Germinal Determinism
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One of the crucial unknowns about reprogramming is whether or not we can understand this phenomenon by invoking well-defined core fundamental principles and mechanisms. Rigorous reprogramming occurs in vivo, especially in germ cells for generating totipotency, and can be induced experimentally in mammalian somatic cells to generate pluripotent cells in vitro. An increasing number of transcriptional factors, epigenetic modifiers, and noncoding RNAs are being identified that contribute to reprogramming, but the in vitro procedures remain highly inefficient and may even be incomplete, which might be improved with further understanding of reprogramming in the germline. Furthermore, we have yet to develop a composite and coherent view of how different conditions and factors together contribute to reprogramming and how they work in different systems. By integrating and linking all available information from in vitro and in vivo systems, it may become possible to replace experimental outcomes that are currently largely stochastic in nature, with deterministic models of reprogramming. Better mechanistic insights on reprogramming of somatic nuclei following transplantation into oocytes and from cell fusions such as somatic-stem cell hybrids could also provide the foundation for the far less developed but potentially exciting experimental approaches for transdifferentiation.
Hatching Hybrids?
Elly Tanaka
Technical University Dresden Although reprogramming has been deemed stochastic, if we understood the intermediate cell states that get the ''foot in the door'' so that a cell becomes amenable to reprogramming, then reprogramming could be experimentally deterministic. For example, epithelialization is associated with reprogramming to pluripotency, but how does the epithelial program change the nucleus so that endogenous Oct4 expression can win out?
Reprogramming studies so far have focused on creating a known cell type, such as an embryonic stem cell, as faithfully as possible. From a regeneration biology viewpoint, I am interested in reprogramming cells to states that do not exist during embryogenesis. There are hints that, during regeneration, progenitor cells achieve hybrid embryonic/adult states-a kind of cellular neoteny, or partial reprogramming. Presumably, this involves novel combinations of genetic regulatory networks that can coexist at least for some time. How are these novel combinations achieved? How deeply must epigenetic control of gene regulation be dismantled to achieve these hybrid states? Can meaningful hybrid states be engineered, and how do they resolve themselves when cells are induced to differentiate? So far, the hybrid states that we have seen combine the embryonic/adult features within a given lineage. Can we meaningfully engineer novel cells that display hybrid character between cells of different lineages, or would this violate a fundamental biological code?
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Appraising Epigenetic Obstacles
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The remarkable discovery of induced pluripotent stem (iPS) cell generation is revolutionizing stem cell biology. It is curious that typically less than one percent of somatic cells are converted to iPS cells despite the relatively uniform expression of the reprogramming transcription factors in all cells. Apparently, genes required for pluripotency are not turned on by these factors in most differentiated cells. This may reflect the general phenomenon that differentiated cell identity is stably locked in by epigenetic mechanisms, in particular by heterochromatinization of genes that are not expressed. During reprogramming, repressive chromatin states may therefore impede binding of the reprogramming factors and activation of pluripotency genes. How the reprogramming factors gain access to these targets is completely unclear and appears to only occur in rare cases. Such a rare event could be the up-or downregulation of a chromatin regulator that can reduce inhibitory epigenetic mechanisms. Related to this, it has been suggested that early development is accompanied by major changes in nuclear architecture, regulation of DNA replication, and global chromatin structure. This genome reorganization occurs prior to germ layer restriction. It is possible that reversing these global changes is a major obstacle for pluripotency gene activation and successful reprogramming. Undoubtedly, understanding the reason for the low efficiency of reprogramming should help to reveal basic concepts underlying differentiation.
